Specialty chemicals maker Rohm and Haas has designed new equipments
for its drug dissolution testing that it claims can reliably
predict the release of oral drugs in vivo, and therefore
potentially reduce the amount of animal testing.
Johnson & Johnson Pharmaceutical Research and Development
(J&JPRD) and the Hurel Corporation have entered into a joint
scientific collaboration to develop microfluidic, technology, with
a view to launching the world's...
A US start-up company specialising in biomaterials, 3DMatrix, has
developed a synthetic scaffold product that can be used to create
self-assembling, microscale environments to encourage the growth of
cells in culture.